1. Home
  2. GOTU vs AUTL Comparison

GOTU vs AUTL Comparison

Compare GOTU & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GOTU

Gaotu Techedu Inc.

HOLD

Current Price

$1.91

Market Cap

469.8M

Sector

Real Estate

ML Signal

HOLD

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.86

Market Cap

407.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GOTU
AUTL
Founded
2014
2014
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.8M
407.2M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
GOTU
AUTL
Price
$1.91
$1.86
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
393.2K
1.7M
Earning Date
05-15-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,120,000.00
Revenue This Year
$17.33
$80.32
Revenue Next Year
$13.02
$53.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
496.00
52 Week Low
$1.65
$1.18
52 Week High
$4.12
$2.70

Technical Indicators

Market Signals
Indicator
GOTU
AUTL
Relative Strength Index (RSI) 52.55 63.25
Support Level $1.86 $1.27
Resistance Level $2.03 $1.98
Average True Range (ATR) 0.08 0.14
MACD -0.00 0.02
Stochastic Oscillator 70.83 82.69

Price Performance

Historical Comparison
GOTU
AUTL

About GOTU Gaotu Techedu Inc.

Gaotu Techedu Inc is a technology-driven education company that provides online live courses in a large-class setting backed by its proprietary technology infrastructure. The company offers courses in large-class format, which amplifies the benefits of online education and allows it to rapidly expand its student base. It operates solely in the PRC and all assets are located in the PRC. The learning services that the company offers include Traditional Learning Services, Non-Academic Tutoring Services, and College Student and Adult Education Services. It derives maximum revenue from Learning Services and also from Educational content & digitalized learning products.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

Share on Social Networks: